State Street’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.55M Buy
730,213
+36,099
+5% +$130K ﹤0.01% 3220
2025
Q4
$2.37M Buy
694,114
+23,097
+3% +$103K ﹤0.01% 3288
2025
Q3
$3.38M Buy
671,017
+56,724
+9% +$250K ﹤0.01% 3147
2025
Q2
$2.11M Sell
614,293
-12,848
-2% -$32K ﹤0.01% 3299
2025
Q1
$1.4M Buy
627,141
+302,339
+93% +$867K ﹤0.01% 3358
2024
Q4
$952K Buy
324,802
+1,573
+0.5% +$4.38K ﹤0.01% 3497
2024
Q3
$840K Buy
323,229
+4,679
+1% +$13K ﹤0.01% 3515
2024
Q2
$943K Sell
318,550
-131,705
-29% -$498K ﹤0.01% 3481
2024
Q1
$2.04M Sell
450,255
-10,645
-2% -$54.3K ﹤0.01% 3273
2023
Q4
$2.63M Buy
460,900
+44,722
+11% +$207K ﹤0.01% 3224
2023
Q3
$1.91M Buy
416,178
+163,738
+65% +$996K ﹤0.01% 3355
2023
Q2
$1.63M Sell
252,440
-3,137,365
-93% -$21.4M ﹤0.01% 3473
2023
Q1
$25.6M Buy
3,389,805
+120,418
+4% +$1.09M ﹤0.01% 2057
2022
Q4
$33.1M Buy
3,269,387
+58,568
+2% +$677K ﹤0.01% 1910
2022
Q3
$31.8M Buy
3,210,819
+16,510
+0.5% +$181K ﹤0.01% 1906
2022
Q2
$34M Buy
3,194,309
+2,925,279
+1,087% +$24.8M ﹤0.01% 1882
2022
Q1
$2.62M Buy
269,030
+89,823
+50% +$850K ﹤0.01% 3468
2021
Q4
$2.56M Buy
179,207
+52,739
+42% +$800K ﹤0.01% 3565
2021
Q3
$2.53M Buy
+126,468
New +$2.24M ﹤0.01% 3548

Other funds holding ABCL